Intellipharmaceutics International (TSE:I) Releases Earnings Results

Intellipharmaceutics International (TSE:IGet Rating) (NASDAQ:IPCI) issued its earnings results on Thursday. The company reported C($0.04) earnings per share (EPS) for the quarter, reports. The firm had revenue of C$0.11 million during the quarter.

Intellipharmaceutics International has a fifty-two week low of C$1.78 and a fifty-two week high of C$4.50. The stock has a fifty day simple moving average of C$3.23.

Intellipharmaceutics International Company Profile (Get Rating)

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals.

See Also

Earnings History for Intellipharmaceutics International (TSE:I)

Receive News & Ratings for Intellipharmaceutics International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intellipharmaceutics International and related companies with MarketBeat.com's FREE daily email newsletter.